US Stock MarketDetailed Quotes

INBX Inhibrx Biosciences

Watchlist
  • 14.080
  • +0.100+0.72%
Close Nov 22 16:00 ET
  • 15.400
  • +1.320+9.38%
Post 20:01 ET
203.82MMarket Cap0.12P/E (TTM)

Inhibrx Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Inhibrx Biosciences Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q41.634M / 50.000K--
--2023/Q3119.000K / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q41.634M / 50.000K--
--2023/Q3119.000K / 0.000--

Unlock Free Earnings Estimates

Inhibrx Biosciences Earnings Reports

  • Inhibrx Biosciences | 10-Q: Quarterly report

    Nov 14 17:20 ET

  • Inhibrx Biosciences | 8-K: Inhibrx Biosciences Reports Third Quarter 2024 Financial Results

    Nov 14 16:32 ET

  • Inhibrx Biosciences | 8-K: Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

    Aug 13 16:13 ET

  • Inhibrx Biosciences | 10-Q: Quarterly report

    Aug 13 16:11 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 18, 2024

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data